Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1β converting enzyme
- 9 September 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (17) , 2181-2186
- https://doi.org/10.1016/s0960-894x(97)00394-6
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- PYRIDONE-BASED PEPTIDOMIMETIC INHIBITORS OF INTERLEUKIN-1β-CONVERTING ENZYME (ICE)Bioorganic & Medicinal Chemistry Letters, 1997
- In vitro and in vivo studies of ICE inhibitorsJournal of Cellular Biochemistry, 1997
- First Examples of Peptidomimetic Inhibitors of Interleukin-1β Converting EnzymeJournal of Medicinal Chemistry, 1996
- Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting EnzymeScience, 1995
- Aspartyl .alpha.-((1-Phenyl-3-(trifluoromethyl)- pyrazol-5-yl)oxy)methyl Ketones as Interleukin-1.beta. Converting Enzyme Inhibitors. Significance of the P1 and P3 Amido Nitrogens for Enzyme-Peptide Inhibitor BindingJournal of Medicinal Chemistry, 1994
- The synthesis and evaluation of peptidyl aspartyl aldehydes as inhibitors of ice.Bioorganic & Medicinal Chemistry Letters, 1994
- Immune Response in Mice that Lack the Interferon-γ ReceptorScience, 1993
- Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ GenesScience, 1993
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992
- Activation of interleukin‐ 1β by a co‐induced proteaseFEBS Letters, 1989